Thorne HealthTech, Inc. (NASDAQ:THRN) Q2 2022 Earnings Conference Call August 10, 2022 8:00 AM ET

Company Participants

Thomas Wilson - Vice President, Investor Relations

Paul Jacobson - Chief Executive Officer

Bryan Conley - Chief Financial Officer

Michelle Crow - Chief Marketing Officer

Conference Call Participants

Sean Dodge - RBC Capital Markets

Oliver Chen - Cowen and Company

Operator

Hello and welcome to today’s Thorne HealthTech Second Quarter 2022 Earnings Call. My name is Bailey, and I will be your moderator for today’s call. All lines will be muted during the presentation portion of the call with an opportunity for questions-and-answers at the end. [Operator Instructions]

I would now like to pass the conference over to our host, Thomas Wilson, Vice President of Investor Relations. Thomas, please go ahead.

Thomas Wilson

Good morning, everyone. Thank you for joining Thorne HealthTech's second quarter 2022 earnings call. With me today to share our results are Paul Jacobson, our CEO; and Bryan Conley, our CFO; Tom McKenna, our COO; and Michelle Crow, our Chief Marketing Officer, are also available for questions.

Before we begin, please note that today's discussion contains forward-looking statements that are subject to risks and uncertainties. Actual results may differ materially from those indicated by our forward-looking statements. More information about potential risk factors can be found in our 2021 annual report on Form 10-K and our upcoming Form 10-Q, which we anticipate filing aftermarket today and in other SEC filings.

Today, in addition to US GAAP reporting, we will be discussing financial measures that do not conform to GAAP. We believe these non-GAAP measures enhance the understanding of our performance because they are more representative of how we internally measure the business. Non-GAAP financial measures should not be considered in isolation from or as a substitute for GAAP measures. A reconciliation of GAAP to non-GAAP results is available in the earnings press release we issued after market close yesterday and in the supplemental investor presentation posted to our IR website.

With that, I'll turn the call over to Paul

Paul Jacobson

Thank you, Thomas. Good morning, everyone. Thank you for joining our second quarter earnings call. I'm pleased to report that we had another successful quarter on our journey to becoming the leading company, healthy aging and personalized scientific wellness. We entered the quarter with an aggressive agenda that included our largest ever marketing campaign aimed at driving significant brand awareness, a slate of important new product launches that span across multiple health areas, and the continued advancement of our proprietary wellness tests, which we expect will further differentiate our holistic offerings and help us build the competitive moat around areas of the wellness space that have not existed before.